malaria preventive therapy (Shionogi/Nagasaki University/MMV/National Institute of Infectious Diseases)

N/A

Report date: 2025/06/11 11:07:33
NME

Base Information

Drug Namemalaria preventive therapy (Shionogi/Nagasaki University/MMV/National Institute of Infectious Diseases)
Drug Alias Nameanti-malarial therapy (Shionogi/Nagasaki University)
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNagasaki UniversityShionogi & Co LtdMedicines for Malaria Venture +[4] 
Inactive CompaniesN/A
Active IndicationsMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A